| 1. |
Abreu C, Rocha-Pereira N, Sarmento A, et al. Nocardia infections among immunomodulated inflammatory bowel disease patients: a review. World J Gastroenterol, 2015, 21(21): 6491-6498.
|
| 2. |
Martínez R, Reyes S, Menéndez R. Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis. Curr Opin Pulmo Med, 2008, 14(3): 219-227.
|
| 3. |
Parte AC. LPSN--list of prokaryotic names with standing in nomenclature. Nucleic Acids Res, 2014, 42(Database issue): 613-616.
|
| 4. |
Menendez R, Cordero PJ, Santos M, et al. Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur Respir J, 1997, 10(7): 1542.
|
| 5. |
Yamagata M, Hirose K, Ikeda K, et al. Clinical characteristics of nocardia infection in patients with rheumatic diseases. Clin Dev Immunol, 2013, 2013(1): 818654.
|
| 6. |
Lee TG, Jin WJ, Jeong WS, et al. Primary cutaneous nocardiosis caused by Nocardia takedensis. Ann Dermatol, 2017, 29(4): 471-475.
|
| 7. |
Hoza AS, Mfinanga SGS, Moser I, et al. Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?. BMC Infect Dis, 2017, 17(1): 407.
|
| 8. |
Yasuo T, Shunsuke I, Takayuki K, et al. Pulmonary nocardiosis: a clinical analysis of 30 cases. Intern Med, 2017, 56(12): 1485-1490.
|
| 9. |
Kandi V. Human nocardia infections: a review of pulmonary nocardiosis. Cureus, 2015, 7(8): e304.
|
| 10. |
Li S, Song XY, Zhao YY, et al. Clinical analysis of pulmonary nocardiosis in patients with autoimmune disease. Medicine, 2015, 94(39): e1561.
|
| 11. |
Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proceed, 2012, 87(4): 403-407.
|
| 12. |
Hashemi-Shahraki A, Heidarieh P, Bostanabad SZ, et al. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis. Sci Rep, 2015, 5: 17862.
|
| 13. |
Uhde KB, Pathak S, McCullum I Jr, et al. Antimicrobial-resistant Nocardia isolates, United States, 1995–2004. Clin Infect Dis, 2010, 51(12): 1445-1448.
|
| 14. |
Larruskain J, Idigoras P, Marimón JM, et al. Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents. Antimicrob Agents Chemother, 2011, 55(6): 2995-2998.
|
| 15. |
Tremblay J, Thibert L, Alarie I, et al. Nocardiosis in Quebec, Canada, 1988–2008. Clin Microbiol Infect, 2011, 17(5): 690-696.
|
| 16. |
Brown-Elliott BA, Biehle J, Conville PS, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol, 2012, 50(3): 670-672.
|
| 17. |
Lai CC, Liu WL, Ko WC, et al. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various nocardia species. Antimicrob Agents Chemother, 2011, 55(5): 2084-2091.
|
